Medline (MDLN) Slips 3.29% on Bearish Patterns Nears Key Support at $40.62 Amid Downtrend
Medline (MDLN) closed the most recent session at $40.62, reflecting a 3.29% decline. This price action suggests a bearish continuation, particularly given the recent intraday low of $40 and the formation of a potential bearish engulfing pattern over the prior two days. Key support levels appear to be consolidating around $40.62 (previous close) and $39.50 (December 18th low), while resistance is likely to be tested at $42.04 (January 2nd high) and $43.08 (December 31st high). The breakdown below the $41.21 pivot point raises the probability of further downward pressure.
Candlestick Theory
The recent price action exhibits a series of lower highs and lower lows, forming a descending channel that aligns with bearish bias. A notable bearish harami pattern emerged on December 29th, with the $42.00 close confined within the prior session’s range. This pattern, combined with the failure to reclaim key psychological levels above $43, suggests a potential test of the $38.82 (December 19th low) support. The 50% Fibonacci retracement level at $40.00 (from the $45.50 high to $34.89 low) could act as a critical threshold for near-term direction.
Moving Average Theory
Short-term momentum is bearish, with the 50-day moving average likely below the 200-day average (death cross configuration), while the 100-day line may be approaching a confluence with the 200-day line. The current price of $40.62 appears to be below all three averages, reinforcing a downtrend. A retest of the 200-day line (approximately $41.50) could trigger a short-term bounce, but sustained strength above $42.04 would be necessary to invalidate the bearish thesis.
MACD & KDJ Indicators
The MACD histogram has contracted into negative territory, with the MACD line crossing below the signal line—a bearish divergence. The KDJ (stochastic oscillator) shows %K and %D lines in oversold territory (below 20), but the lack of a bullish crossover suggests exhaustion rather than reversal potential. A divergence between price and KDJ could emerge if the stock breaks below $40.00 without a corresponding rally in the indicator, signaling further weakness.
Volatility has expanded sharply, with the 20-day Bollinger Bands stretching to $42.04 (upper) and $39.50 (lower). The current price near the lower band indicates extreme bearish momentum, though a rebound to the mid-band ($40.77) could provide a temporary floor. Band contraction observed on December 26th preceded the recent selloff, suggesting that a period of consolidation may follow a potential bounce.
Volume-Price Relationship
The recent session’s volume of 7.35 million shares is above the 20-day average, validating the bearish move. However, the December 17th session saw an anomalous 78.9 million shares traded amid a $34.89 low, indicating potential distribution or panic selling. A surge in volume during a rebound attempt could confirm a short-covering rally, while declining volume during further declines may signal capitulation.
Relative Strength Index (RSI)
The 14-day RSI is near 28, indicating oversold conditions. However, this reading should be interpreted cautiously, as the RSI has remained in oversold territory for multiple sessions, suggesting a structural breakdown rather than a temporary correction. A move above 40 would be necessary to alleviate bearish pressure, but this is unlikely without a significant reversal pattern.
Fibonacci Retracement
Key Fibonacci levels from the $45.50 high to $34.89 low include 38.2% at $41.05 and 61.8% at $38.20. The current price near $40.62 is testing the 50% retracement level, which often acts as a psychological pivot. A breakdown below $38.82 would target the 61.8% level, while a bounce above $41.05 could reestablish a short-term equilibrium.
Confluence between candlestick breakdowns, oversold RSI, and bearish MACD strengthens the case for further declines to $38.20. Divergences between KDJ and price suggest the selloff may lack conviction, though volume validates the move. A key divergence to monitor is a price rebound to $42.04 without corresponding strength in the RSI or MACD, which would indicate a bear trap. Probability remains skewed to the downside in the near term, with a 60% chance of a test of $38.82 and a 40% chance of a countertrend bounce to $41.05.
If I have seen further, it is by standing on the shoulders of giants.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet